Launay-Vacher, Vincent <br/><br/>
Evolution of renal function in patients treated with antiangiogenics after nephrectomy for renal cell carcinoma.  [electronic resource] 

 -  Urologic oncology   
 - 492-4 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1873-2496 
<br/><br/><label>Standard No.: </label>10.1016/j.urolonc.2009.07.023  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antibodies, Monoclonal, Humanized--administration & dosage<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Benzenesulfonates--administration & dosage<br/>Bevacizumab<br/>Carcinoma, Renal Cell--blood supply<br/>Combined Modality Therapy<br/>Female<br/>Follow-Up Studies<br/>Glomerular Filtration Rate<br/>Humans<br/>Indoles--administration & dosage<br/>Kidney Neoplasms--blood supply<br/>Male<br/>Middle Aged<br/>Neoplasm Staging<br/>Neovascularization, Pathologic--prevention & control<br/>Nephrectomy<br/>Niacinamide--analogs & derivatives<br/>Phenylurea Compounds<br/>Prognosis<br/>Pyridines--administration & dosage<br/>Pyrroles--administration & dosage<br/>Retrospective Studies<br/>Sorafenib<br/>Sunitinib<br/>Survival Rate